{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:12:23Z","timestamp":1761765143433},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1097\/mjt.0b013e31816ddb5d","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T15:29:24Z","timestamp":1242919764000},"page":"127-132","source":"Crossref","is-referenced-by-count":5,"title":["Improvement in Sensory Pain Rating After Palliative Systemic Radionuclide Therapy in Patients With Advanced Prostate Cancer"],"prefix":"10.1097","volume":"16","author":[{"given":"Frank J","family":"Papatheofanis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Najib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-5-20210202","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/suro.2002.30390","article-title":"Prostate cancer incidence, mortality, and survival trends in the United States: 1981-2001.","volume":"20","author":"Sarma","year":"2002","journal-title":"Semin Urol Oncol"},{"key":"R4-5-20210202","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0305-7372(96)90021-3","article-title":"Effects of bone metastases on bone metabolism: implications for diagnosis, imaging and assessment of response to cancer treatment.","volume":"22","author":"Vinholes","year":"1996","journal-title":"Cancer Treat Rev"},{"key":"R5-5-20210202","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/0885-3924(95)00003-H","article-title":"Assessment of pain in advanced cancer patients.","volume":"10","author":"Shannon","year":"1995","journal-title":"J Pain Symptom Manage"},{"key":"R6-5-20210202","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0304-3959(75)90044-5","article-title":"The McGill Pain Questionnaire: major properties and scoring methods.","volume":"1","author":"Melzack","year":"1975","journal-title":"Pain"},{"key":"R7-5-20210202","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1200\/JCO.1984.2.5.472","article-title":"Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation.","volume":"2","author":"Schipper","year":"1984","journal-title":"J Clin Oncol"},{"key":"R8-5-20210202","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1200\/JCO.1993.11.3.570","article-title":"The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.","volume":"11","author":"Cella","year":"1993","journal-title":"J Clin Oncol"},{"key":"R9-5-20210202","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0885-3924(03)00255-0","article-title":"Use of oral and transdermal opioids among patients with metastatic cancer during the last year of life.","volume":"26","author":"Berger","year":"2003","journal-title":"J Pain Symptom Manage"},{"key":"R10-5-20210202","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1464-410X.2003.04321.x","article-title":"Health-related quality of life and psychosocial factors in patients with prostate cancer scheduled for radical prostatectomy or external radiation therapy.","volume":"92","author":"Van Andel","year":"2003","journal-title":"BJU Int"},{"key":"R11-5-20210202","doi-asserted-by":"crossref","first-page":"56","DOI":"10.12968\/ijpn.2003.9.2.56","article-title":"Is opiate compliance a problem in cancer pain? A survey of health-care professionals views.","volume":"9","author":"Abbas","year":"2003","journal-title":"Int J Palliat Nurs"},{"key":"R12-5-20210202","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0305-7372(03)00013-6","article-title":"Bisphosphonates and radiation therapy for palliation of metastatic bone disease.","volume":"29","author":"Hoskin","year":"2003","journal-title":"Cancer Treat Rev"},{"key":"R13-5-20210202","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0302-2838(03)00364-6","article-title":"Strontium(89) chloride versus palliative local field radiotherapy in patients with hormonal escaped prostate cancer: a phase III study of the European Organisation for Research and Treatment of Cancer, Genitourinary Group.","volume":"44","author":"Oosterhof","year":"2003","journal-title":"Eur Urol"},{"key":"R14-5-20210202","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.radonc.2005.03.003","article-title":"Radiopharmaceuticals for the palliation of painful bone metastasis-a systemic review.","volume":"75","author":"Bauman","year":"2005","journal-title":"Radiother Oncol"},{"key":"R15-5-20210202","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1046\/j.1526-4637.2003.03006.x","article-title":"Physician variability in the management of acute postoperative and cancer pain: a quantitative analysis of the Michigan experience.","volume":"4","author":"Green","year":"2003","journal-title":"Pain Med"},{"key":"R16-5-20210202","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1054\/jpai.2003.5","article-title":"Clinical decision making in pain management: contributions of physician and patient characteristics to variations in practice.","volume":"4","author":"Green","year":"2003","journal-title":"J Pain"},{"key":"R17-5-20210202","first-page":"1420","article-title":"Variation in oncologic opinion regarding management of metastatic bone pain with systemic radionuclide therapy.","volume":"40","author":"Papatheofanis","year":"1999","journal-title":"J Nucl Med"},{"key":"R18-5-20210202","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0885-3924(93)90126-G","article-title":"The short-form McGill Pain Questionnaire in chronic cancer pain.","volume":"8","author":"Dudgeon","year":"1993","journal-title":"J Pain Symptom Manage"},{"key":"R19-5-20210202","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0304-3959(80)90081-0","article-title":"Use of the McGill pain questionnaire in the assessment of cancer pain: replicability and consistency.","volume":"8","author":"Graham","year":"1980","journal-title":"Pain"},{"key":"R20-5-20210202","first-page":"1814","article-title":"Human pharmacokinetics of samarium-153 EDTMP in metastatic cancer.","volume":"30","author":"Singh","year":"1989","journal-title":"J Nucl Med"},{"key":"R22-5-20210202","first-page":"1","article-title":"Agency for Health Care Policy and Research.","volume":"9","year":"1994","journal-title":"Clin Pract Guidel Quick Ref Guide Clin"},{"key":"R23-5-20210202","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1200\/JCO.2004.10.524","article-title":"Nonsteroidal anti-inflammatory drugs, alone or combined with opioids, for cancer pain: a systematic review.","volume":"22","author":"McNicol","year":"2004","journal-title":"J Clin Oncol"},{"key":"R24-5-20210202","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1200\/JCO.1994.12.12.2756","article-title":"Efficacy and safety of nonsteroidal antiinflammatory drugs for cancer pain: a meta-analysis.","volume":"12","author":"Eisenberg","year":"1994","journal-title":"J Clin Oncol"},{"key":"R26-5-20210202","first-page":"1853","article-title":"Management of cancer pain: adults. Cancer Pain Guideline Panel.","volume":"49","year":"1994","journal-title":"Am Fam Physician"},{"key":"R27-5-20210202","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1001\/archneur.57.12.1727","article-title":"Altered mental status in patients with cancer.","volume":"57","author":"Tuma","year":"2000","journal-title":"Arch Neurol"},{"key":"R28-5-20210202","doi-asserted-by":"crossref","first-page":"121","DOI":"10.7326\/0003-4819-119-2-199307150-00005","article-title":"Physician attitudes and practice in cancer pain management. A survey from the Eastern Cooperative Oncology Group.","volume":"119","author":"Von Roenn","year":"1993","journal-title":"Ann Intern Med"},{"key":"R31-5-20210202","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/hmg\/ddi013","article-title":"Genetic basis for individual variations in pain perception and the development of a chronic pain condition.","volume":"14","author":"Diatchenko","year":"2005","journal-title":"Hum Mol Genet"},{"key":"R32-5-20210202","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.urology.2004.01.034","article-title":"Samarium-153-Lexidronam complex for treatment of painful bone metastases in hormone-refractory prostate cancer.","volume":"63","author":"Sartor","year":"2004","journal-title":"Urology"},{"key":"R33-5-20210202","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1200\/JCO.1998.16.4.1574","article-title":"Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trial.","volume":"16","author":"Serafini","year":"1998","journal-title":"J Clin Oncol"},{"key":"R34-5-20210202","first-page":"1839","article-title":"Samarium-153-EDTMP in bone metastases of hormone refractory prostate carcinoma: a phase I\/II trial.","volume":"34","author":"Collins","year":"1993","journal-title":"J Nucl Med"},{"key":"R35-5-20210202","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0959-8049(97)00155-X","article-title":"A dose-controlled study of 153Sm-ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastases.","volume":"33","author":"Resche","year":"1997","journal-title":"Eur J Cancer"},{"key":"R37-5-20210202","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4103\/0019-509X.25890","article-title":"Samarium-153 ethylenediamine tetramethylene phosphonate therapy for bone pain palliation in skeletal metastases.","volume":"43","author":"Tripathi","year":"2006","journal-title":"Indian J Cancer"},{"key":"R38-5-20210202","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/cncr.22431","article-title":"Safety and efficacy of repeat administration of samarium Sm-153 lexidronam to patients with metastatic bone pain.","volume":"109","author":"Sartor","year":"2007","journal-title":"Cancer"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00045391-200903000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:39:52Z","timestamp":1618036792000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045391-200903000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0b013e31816ddb5d","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}